Hamid Saadati
Overview
Explore the profile of Hamid Saadati including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
75
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lacy J, Saadati H, Yu J
Hematol Oncol Clin North Am
. 2012 Jul;
26(4):779-96.
PMID: 22794283
The diverse medical and neurologic complications of central nervous system (CNS) neoplasms or their treatment cause significant morbidity and mortality. Thus, their recognition and appropriate management by all members of...
2.
Hofstatter E, Saadati H, Russell K, Russell 3rd R
Curr Cardiol Rev
. 2012 Jul;
7(4):258-61.
PMID: 22758627
Because of the paucity of large, randomized trials concerning the cardiac care of patients with cancer, treatment and prevention of chemotherapy-induced cardiotoxicity must rely on insights gained from small trials...
3.
Butt W, Saadati H, Saif M
Anticancer Res
. 2010 Dec;
30(12):5113-5.
PMID: 21187498
Background: Drug-induced pancreatitis is less common compared to other causes of acute pancreatitis; the incidence ranges from between 0.1% to 2% of acute pancreatitis cases. Among alkylating agents, oxaliplatin has...
4.
5.
Saadati H, Peccerillo J, Kaley K, Schilsky M, Saif M
JOP
. 2009 Sep;
10(5):573-5.
PMID: 19734642
No abstract available.
6.
Saadati H, Saif M
JOP
. 2009 Jul;
10(4):459-61.
PMID: 19581758
A recent pooled analysis and a meta-analysis suggested a survival benefit of gemcitabine-platinum doublets when compared with single agent gemcitabine in pancreatic cancer. Sensory neurotoxicity is a potentially limiting toxicity...
7.
Borad M, Saadati H, Lakshmipathy A, Campbell E, Hopper P, Jameson G, et al.
Yale J Biol Med
. 2009 Mar;
82(1):1-6.
PMID: 19325940
Background: Skeletal metastases represent an underappreciated site of metastasis in patients with pancreatic cancer. Previous reports have estimated the prevalence to range from 5 percent to 20 percent. With the...
8.
9.
Bennett J, DeFreest L, Anaka I, Saadati H, Balulad S, Jacobson H, et al.
Breast Cancer Res Treat
. 2006 Mar;
98(2):133-41.
PMID: 16538538
Background: We have synthesized a cyclic nonapeptide (AFPep) that is effective, after being administered by parenteral routes, for the treatment or the prevention of breast cancer. To test the hypothesis...